Correlation Between Tissue and Plasmatic EGFR in CBNPC With EGFR Mutation or Predictive Factor of EGFR Mutation (CONCORDE)
Sponsor: Centre Oscar Lambret
Terminated
The number of recruted patient was not sufficient
Other terminated trials from Centre Oscar Lambret
Listed as NCT03265496, this NA trial focuses on Nsclc and remains terminated or withdrawn. Sponsored by Centre Oscar Lambret, it has been updated 8 times since 2016, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
8 versions recorded-
Sep 2024 — Present [monthly]
Terminated NA
-
Jul 2024 — Sep 2024 [monthly]
Terminated NA
-
Nov 2021 — Jul 2024 [monthly]
Terminated NA
Status: Active Not Recruiting → Terminated
-
Jan 2021 — Nov 2021 [monthly]
Active Not Recruiting NA
-
Apr 2020 — Jan 2021 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
▶ Show 3 earlier versions
-
Jun 2019 — Apr 2020 [monthly]
Recruiting NA
-
Jun 2018 — Jun 2019 [monthly]
Recruiting NA
-
Sep 2017 — Jun 2018 [monthly]
Recruiting NA
First recorded
Jul 2016
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Centre Oscar Lambret
- University Hospital, Lille
For direct contact, visit the study record on ClinicalTrials.gov .